Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy

Several retrospective and a few prospective studies have shown that metastasis-directed therapy (MDT) could delay clinical progression and postpone the initiation of systemic treatment in oligorecurrent prostate cancer (PCa) patients. However, these endpoints are strongly influenced by variables suc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Devos, Gaëtan, Berghen, Charlien, Van Eecke, Henri, Stichele, Arthur Vander, Van Poppel, Hendrik, Goffin, Karolien, Mai, Cindy, De Wever, Liesbeth, Albersen, Maarten, Everaerts, Wouter, De Meerleer, Gert, Joniau, Steven
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7464259/
https://ncbi.nlm.nih.gov/pubmed/32823690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082271
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak